Legence (NASDAQ:LGN) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate of $0.02 by 2391.67 percent. The company reported quarterly sales of $737.642 million which beat the analyst consensus estimate of $620.307 million by 18.92 percent. This is a 34.55 percent increase over sales of $548.215 million the same period last year.